• Oracle (NASDAQ:ORCL) reported fiscal second quarter earnings of $0.51, beating the Zacks Consensus Estimate of $0.44, on revenues of $8.6 billion that topped the Zacks Consensus Estimate of $8.3 billion
• Take-Two Interactive Software (NASDAQ:TTWO) posted stronger fiscal fourth quarter earnings of $0.67 ahead the Zacks Consensus Estimate of $0.23, revenues up 32% to $374 million, ahead of Zacks Consensus Estimate of$ 223 million.
• Research In Motion’s (NASDAQ:RIMM) posted third quarter earnings of $1.74 ahead of the Zacks Consensus Estimate of $1.64, as revenues increased by 19% to $5.5 billion, ahead of the Zacks Consensus Estimate of $5.49 billion
• Accenture’s (NYSE:ACN) reported fiscal first quarter earnings of $0.81 ahead of the Zacks Consensus Estimate of $0.75, as revenues increased by 32% to $6.1 billion, ahead of the Zacks Consensus Estimate of $5.54 billion
• AstraZeneca’s (NYSE:AZN) new heart drug Brilinta failed to succeed in getting regulatory approval in the US
• BMO Financial announced their plans to purchase Marshall & Ilsley (NYSE:MI) for $4.1 billion
• JP Morgan (NYSE:JPM) upgraded Aon (NYSE:AON) to “overweight”
ACCENTURE PLC (ACN): Free Stock Analysis Report
AON CORP (AON): Free Stock Analysis Report
ASTRAZENECA PLC (AZN): Free Stock Analysis Report
JPMORGAN CHASE (JPM): Free Stock Analysis Report
MARSHALL&ILSLEY (MI): Free Stock Analysis Report
ORACLE CORP (ORCL): Free Stock Analysis Report
RESEARCH IN MOT (RIMM): Free Stock Analysis Report
TAKE-TWO INTER (TTWO): Free Stock Analysis Report
Zacks Investment Research
